Washington D.C. [US], Oct. 18 (ANI
): In a recent research conducted at the University of Arizona, scientists have found that having a higher body mass index (BMI), can negatively impact cognitive functioning in older adults.
"The higher your BMI, the more your inflammation goes up," said Kyle Bourassa, the lead author of the study.
Previous studies also have linked higher BMI to lower cognitive functioning. However, how and why the two are connected was far less clear.
"We saw this effect, but it's a black box. What goes in between? Establishing what biologically plausible mechanisms explain this association is important to be able to intervene later," said Bourassa.
The team analyzed data from the English Longitudinal Study of Aging, which includes over 12 years' worth of information on the health, well-being and social and economic circumstances of the English population age 50 and older.
Using two separate samples from the study, one of about 9,000 people and one of about 12,500, researchers looked at aging adults over a six-year period.
With information about participants' BMI, inflammation and cognition, they found the same outcome in both samples.
"The higher participants' body mass at the first time point in the study, the greater the change in their CRP levels over the next four years. CRP stands for C-reactive protein, which is a marker in the blood of systemic inflammation in your body. Change in CRP over four years then predicted change in cognition six years after the start of the study. The body mass of these people predicted their cognitive decline through their levels of systemic inflammation," he said.
The findings support existing literature linking inflammation to cognitive decline and take it a step further by illuminating the important role of body mass in the equation.
"The findings provide a clear and integrative account of how BMI is associated with cognitive decline through systemic inflammation, but we need to remember that these are only correlational findings. Of course, correlation does not equal causation. The findings suggest a mechanistic pathway, but we cannot confirm causality until we reduce body mass experimentally, then examine the downstream effects on inflammation and cognition," he said.
Adding, "Experimental studies finding whether reducing inflammation also improves cognition would be the gold standard to establish that this is a causal effect."
Cognitive decline is a normal part of aging, even in healthy adults, and can have a significant impact on quality of life.
The current research may provide valuable insights for possible interventions and new research directions in that area.
"If you have high inflammation, in the future we may suggest using anti-inflammatories not just to bring down your inflammation but to hopefully also help with your cognition. Having a lower body mass is just good for you, period. It's good for your health and good for your brain," he concluded.
The study was published in the journal Brain, Behavior and Immunity. (ANI